Citigroup’s ChemoCentryx, Inc. CCXI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-141,170
| Closed | -$7.29M | – | 6187 |
|
|
2022
Q3 | $7.29M | Sell |
141,170
-18,257
| -11% | -$755K | 0.01% | 1321 |
|
|
2022
Q2 | $3.95M | Buy |
159,427
+117,029
| +276% | +$2.58M | ﹤0.01% | 1668 |
|
|
2022
Q1 | $1.06M | Sell |
42,398
-90,869
| -68% | -$2.55M | ﹤0.01% | 2904 |
|
|
2021
Q4 | $4.85M | Sell |
133,267
-70,233
| -35% | -$2.47M | ﹤0.01% | 1858 |
|
|
2021
Q3 | $3.48M | Sell |
203,500
-126,118
| -38% | -$1.97M | ﹤0.01% | 2061 |
|
|
2021
Q2 | $4.41M | Buy |
329,618
+215,193
| +188% | +$5.3M | ﹤0.01% | 2010 |
|
|
2021
Q1 | $5.86M | Buy |
114,425
+101,840
| +809% | +$6.13M | ﹤0.01% | 1681 |
|
|
2020
Q4 | $779K | Buy |
12,585
+6,283
| +100% | +$360K | ﹤0.01% | 3792 |
|
|
2020
Q3 | $345K | Sell |
6,302
-199,868
| -97% | -$10.8M | ﹤0.01% | 4174 |
|
|
2020
Q2 | $11.9M | Buy |
206,170
+179,840
| +683% | +$9.79M | 0.01% | 1178 |
|
|
2020
Q1 | $1.06M | Buy |
26,330
+6,894
| +35% | +$293K | ﹤0.01% | 3115 |
|
|
2019
Q4 | $769K | Buy |
19,436
+15,880
| +447% | +$279K | ﹤0.01% | 4029 |
|
|
2019
Q3 | $24K | Sell |
3,556
-99,336
| -97% | -$746K | ﹤0.01% | 6636 |
|
|
2019
Q2 | $957K | Buy |
102,892
+96,063
| +1,407% | +$1.11M | ﹤0.01% | 3683 |
|
|
2019
Q1 | $95K | Buy |
6,829
+2,756
| +68% | +$31.5K | ﹤0.01% | 5792 |
|
|
2018
Q4 | $45K | Sell |
4,073
-400
| -9% | -$4.22K | ﹤0.01% | 6321 |
|
|
2018
Q3 | $57K | Buy |
4,473
+2,362
| +112% | +$28.5K | ﹤0.01% | 6416 |
|
|
2018
Q2 | $28K | Sell |
2,111
-1,204
| -36% | -$14.4K | ﹤0.01% | 6755 |
|
|
2018
Q1 | $45K | Buy |
3,315
+2,092
| +171% | +$21.6K | ﹤0.01% | 6245 |
|
|
2017
Q4 | $7K | Sell |
1,223
-620
| -34% | -$4.25K | ﹤0.01% | 7161 |
|
|
2017
Q3 | $14K | Buy |
1,843
+1,682
| +1,045% | +$14K | ﹤0.01% | 6592 |
|
|
2017
Q2 | $2K | Buy |
161
+152
| +1,689% | +$1.12K | ﹤0.01% | 7054 |
|
|
2017
Q1 | $0 | Buy |
+9
| New | +$65 | ﹤0.01% | 7395 |
|
|
2016
Q4 | – | Sell |
-9,593
| Closed | -$58K | – | 7377 |
|
|
2016
Q3 | $58K | Buy |
9,593
+7,477
| +353% | +$35.3K | ﹤0.01% | 5584 |
|
|
2016
Q2 | $10K | Sell |
2,116
-26,526
| -93% | -$99.5K | ﹤0.01% | 6563 |
|
|
2016
Q1 | $72K | Buy |
28,642
+21,284
| +289% | +$77.5K | ﹤0.01% | 5901 |
|
|
2015
Q4 | $60K | Buy |
7,358
+7,354
| +183,850% | +$52K | ﹤0.01% | 5790 |
|
|
2015
Q3 | $0 | Sell |
4
-5,870
| -100% | -$42.4K | ﹤0.01% | 7855 |
|
|
2015
Q2 | $48K | Sell |
5,874
-1,534
| -21% | -$12.2K | ﹤0.01% | 5566 |
|
|
2015
Q1 | $56K | Sell |
7,408
-6,934
| -48% | -$54.2K | ﹤0.01% | 5483 |
|
|
2014
Q4 | $98K | Buy |
14,342
+13,362
| +1,363% | +$70.7K | ﹤0.01% | 5243 |
|
|
2014
Q3 | $4K | Sell |
980
-964
| -50% | -$5.1K | ﹤0.01% | 6677 |
|
|
2014
Q2 | $11K | Sell |
1,944
-5,088
| -72% | -$28.6K | ﹤0.01% | 6141 |
|
|
2014
Q1 | $46K | Sell |
7,032
-4,831
| -41% | -$33.6K | ﹤0.01% | 5539 |
|
|
2013
Q4 | $69K | Buy |
11,863
+11,831
| +36,972% | +$61K | ﹤0.01% | 5533 |
|
|
2013
Q3 | $0 | Hold |
32
| – | – | ﹤0.01% | 7052 |
|
|
2013
Q2 | $0 | Buy |
+32
| New | +$415 | ﹤0.01% | 6814 |
|
Other funds holding CCXI
Citigroup's CCXI Position: Q4 2022 in Review
Citigroup sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 141,170 shares — an estimated $7.29M sold.
Citigroup first reported a position in CCXI in Q2 2013 and held it in 37 quarters. The position peaked at $11.9M in Q2 2020. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.
- Citigroup reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
- Citigroup sold 141,170 ChemoCentryx, Inc. shares in Q4 2022, an estimated $7.29M.
- Citigroup first reported a position in ChemoCentryx, Inc. in Q2 2013 and held it in 37 quarters.
- Citigroup's ChemoCentryx, Inc. position peaked at $11.9M in Q2 2020.
- 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.
Based on Citigroup's 13F filing for Q4 2022, filed 9 Feb 2023.